GGrantIndex
Sort

78,016 grants matching breast cancer

Project 3: From Networks and Structures to Hierarchical Whole­ Cell Models of Cancer

$472,142
Trey Ideker · University Of California, San Francisco · U54 · FY2024 · CA

A partnership to enable clinical ctDNA testing for breast cancer recurrence

$472,123
Katherine Elena Varley · University Of Utah · R01 · FY2018 · CA

A partnership to enable clinical ctDNA testing for breast cancer recurrence

$472,123
Katherine Elena Varley · University Of Utah · R01 · FY2020 · CA

Project 2: Integrating race, ethnicity, and genomic ancestry across GENIE to understand genetic and environmental contributions to pan-cancer risk, prognosis, and outcomes

$472,108
Jian Zhang · Sloan-Kettering Inst Can Research · P01 · FY2024 · CA

BRCA1 and BRCA2: Homology-Directed DNA Repair and Breast Cancer

$472,108
Maria Jasin · Sloan-Kettering Inst Can Research · P01 · FY2011 · CA

Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model

$472,052
David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA

Basic and Translational Research Center for Reducing Health Disparities

$471,977
Jesus Alexander Angulo · Hunter College · G12 · FY2017 · MD

Mitigating Cancer Treatment-Related Fatigue by Exercise

$471,921
Johns Hopkins University · R01 · FY2002 · NR

Core 1: Information Technology and Systems Integration

$471,913
Adam Asare · University Of California, San Francisco · P01 · FY2025 · CA

High Speed, High Resolution Slide Scanner for Research in Translational Medicine

$471,886
John S Condeelis · Albert Einstein College Of Medicine · S10 · FY2022 · OD

Prognosis in BRCA1 Associated Breast Cancer

$471,855
Mt Sinai Hosp-Samuel Lunenfeld Res Inst · R01 · FY2005 · CA

Therapeutic Targeting of Breast Cancer Tumor Initiating Cells

$471,844
Jeffrey Rosen · Baylor College Of Medicine · R01 · FY2014 · CA

The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer

$471,840
Lewis C Cantley · Beth Israel Deaconess Medical Center · P01 · FY2010 · CA

Next generation deep tissue quantitative optical imaging

$471,795
Thomas D Osullivan · University Of Notre Dame · R01 · FY2021 · EB

Equipment for Correlative LM/EM by High Pressure Freezing and Tomography

$471,762
Kent L. McDonald · University Of California Berkeley · S10 · FY2007 · RR

Measurement Errors in Cancer Epidemiology

$471,729
Donna L Spiegelman · Harvard School Of Public Health · R01 · FY2012 · CA

Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors

$471,719
Laura Q Rogers · University Of Alabama At Birmingham · R01 · FY2020 · CA

Assembly and function of outer membrane tubules in Fusobacterium nucleatum

$471,710
Hung Ton-That · University Of California Los Angeles · R01 · FY2025 · DE

Biochemical Mechanisms and Function of DNA Helicases

$471,697
Stephen Charles Kowalczykowski · University Of California At Davis · R01 · FY2011 · GM

PREcision Disease preventIon via somatiC muTagenesis enumeratION (PREDICTION)

$471,680
Jason H Bielas · Fred Hutchinson Cancer Research Center · U01 · FY2018 · ES

Precision disease prevention via somatic mutagenesis enumeration (PREDICTION)

$471,680
Jason H Bielas · Fred Hutchinson Cancer Research Center · U01 · FY2019 · ES

Precision disease prevention via somatic mutagenesis enumeration (PREDICTION)

$471,680
Eric C Holland · Fred Hutchinson Cancer Center · U01 · FY2022 · ES

Precision disease prevention via somatic mutagenesis enumeration (PREDICTION)

$471,680
Jason H Bielas · Fred Hutchinson Cancer Research Center · U01 · FY2020 · ES

Investigating the Role of Emergent Oscillations of Hypoxia Inducible Factor-1 alpha Activity in Cancer Growth and Progression

$471,661
Fnu Kshitiz · University Of Connecticut Sch Of Med/Dnt · R37 · FY2024 · CA

Project 3: Transcriptomic subtypes, response predictions, and therapy selection

$471,647
Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA